Diagnostic concordance of reporting lymphovascular invasion in breast cancer
暂无分享,去创建一个
I. Ellis | S. Pinder | E. Rakha | Areeg Abbas | Maysa E ElSayed | Pablo Pinto Ahumada | Derek Colman
[1] S. Edge,et al. Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.
[2] Ian O Ellis,et al. Review of the national external quality assessment (EQA) scheme for breast pathology in the UK , 2016, Journal of Clinical Pathology.
[3] A. Mukherjee,et al. Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer , 2015, Pathobiology.
[4] I. Ellis,et al. Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer , 2014, BMC Cancer.
[5] M. Morrow,et al. Estrogen Receptor, Progesterone Receptor, and HER2 Status Predict Lymphovascular Invasion and Lymph Node Involvement , 2014, Annals of Surgical Oncology.
[6] S. Stacker,et al. Lymphangiogenesis and lymphatic vessel remodelling in cancer , 2014, Nature Reviews Cancer.
[7] I. Ellis,et al. The prognostic significance of lymphovascular invasion in invasive breast carcinoma , 2012, Cancer.
[8] Darren Treanor,et al. Observer agreement comparing the use of virtual slides with glass slides in the pathology review component of the POSH breast cancer cohort study , 2012, Journal of Clinical Pathology.
[9] M. Park,et al. The Role of Lymphovascular Invasion as a Prognostic Factor in Patients with Lymph Node-Positive Operable Invasive Breast Cancer , 2011, Journal of breast cancer.
[10] I. Ellis,et al. Objective assessment of lymphatic and blood vascular invasion in lymph node‐negative breast carcinoma: findings from a large case series with long‐term follow‐up , 2011, The Journal of pathology.
[11] V. Brouste,et al. Re: Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. , 2010, Journal of the National Cancer Institute.
[12] B. Rasmussen,et al. Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. , 2009, Journal of the National Cancer Institute.
[13] A. Luini,et al. Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] I. Ellis,et al. Impact of a national external quality assessment scheme for breast pathology in the UK , 2006, Journal of Clinical Pathology.
[15] I. Ellis,et al. The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal , 2006, Journal of Clinical Pathology.
[16] I. Olivotto,et al. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy. , 2005, Journal of the American College of Surgeons.
[17] Karen A Gelmon,et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Pathology reporting in breast cancer screening , 2004 .
[19] Helena R. Chang,et al. Clinicopathologic Analysis of Sentinel Lymph Node Mapping in Early Breast Cancer , 2003, The breast journal.
[20] A. Bianco,et al. The prognostic value of lymphatic and blood vessel invasion in operable breast cancer , 1995, Cancer.
[21] A. Silman,et al. Statistical methods for assessing observer variability in clinical measures. , 1992, BMJ.
[22] A. Lee,et al. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.